Gerald Horn, MD, Ophthalmology, Hinsdale, IL

GeraldDavidHornMDLumify, PRX100 reading drop (inventor)

Ophthalmology Hinsdale, IL

Refractive Surgery

Co-Medical Director Lasik Plus Chicago

Dr. Horn is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Horn's full profile

Already have an account?

Summary

  • Dr. Gerald Horn is an ophthalmologist in Hinsdale, IL. He received his medical degree from University of Illinois College of Medicine and has been in practice 40 years. He is experienced in refractive surgery and refractive laser eye surgery.

Education & Training

  • Rush University Medical Center
    Rush University Medical CenterResidency, Ophthalmology, 1978 - 1981
  • Rush University Medical Center
    Rush University Medical CenterResidency, General Surgery, 1977 - 1978
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1977

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1978 - 2020
  • American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Press Mentions

  • Ocuphire Pharma Announces in-License of Phase 2 Oral Small Molecule Drug Candidate for Diabetic Retinopathy and Diabetic Macular Edema from Apexian Pharmaceuticals
    Ocuphire Pharma Announces in-License of Phase 2 Oral Small Molecule Drug Candidate for Diabetic Retinopathy and Diabetic Macular Edema from Apexian PharmaceuticalsJanuary 22nd, 2020
  • Ocuphire Pharma Announces Results from Two Phase 2 Clinical Studies of Nyxol® Eye Drops
    Ocuphire Pharma Announces Results from Two Phase 2 Clinical Studies of Nyxol® Eye DropsNovember 7th, 2019
  • Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials for Nyxol® Eye Drops
    Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials for Nyxol® Eye DropsSeptember 4th, 2019
  • Join now to see all